Categories AlphaGraphs, Earnings, Health Care
Key highlights from Biogen’s (BIIB) Q3 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today.
Total revenue decreased 3% year-over-year to $2.46 billion. Revenues were down 3% on a constant currency basis as well.
Net income attributable to Biogen Inc. was $388.5 million, or $2.66 per share, compared to a loss of $68.1 million, or $0.47 per share, last year. Adjusted EPS decreased 6% to $4.08.
For the full year of 2024, Biogen expects total revenue to decline by a low-single-digit percentage compared to the previous year. Adjusted EPS is expected to be $16.10-16.60.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
STZ Infographic: A snapshot of Constellation Brands’ Q4 2025 report
Constellation Brands, Inc. (NYSE: STZ) Thursday announced financial results for the fourth quarter of fiscal 2025, reporting an increase in adjusted earnings. Fourth-quarter net sales edged up 1% year-over-year to
Key highlights from CarMax’s (KMX) Q4 2025 earnings results
CarMax, Inc. (NYSE: KMX) reported its fourth quarter 2025 earnings results today. Net revenues of $6 billion were up 6.7% from the same period a year ago. Net earnings increased
American Express (AXP) likely to report higher Q1 revenue and profit
American Express Company (NYSE: AXP) has continued its profitable growth trajectory amid stable demand for its services and strong consumer engagement. That is despite a slowdown in spending among small
